BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 11959975)

  • 1. Mechanism of inactivation on prion conversion of the Saccharomyces cerevisiae Ure2 protein.
    Baxa U; Speransky V; Steven AC; Wickner RB
    Proc Natl Acad Sci U S A; 2002 Apr; 99(8):5253-60. PubMed ID: 11959975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The prion domain of yeast Ure2p induces autocatalytic formation of amyloid fibers by a recombinant fusion protein.
    Schlumpberger M; Wille H; Baldwin MA; Butler DA; Herskowitz I; Prusiner SB
    Protein Sci; 2000 Mar; 9(3):440-51. PubMed ID: 10752606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The [URE3] yeast prion results from protein aggregates that differ from amyloid filaments formed in vitro.
    Ripaud L; Maillet L; Immel-Torterotot F; Durand F; Cullin C
    J Biol Chem; 2004 Dec; 279(49):50962-8. PubMed ID: 15456789
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prion generation in vitro: amyloid of Ure2p is infectious.
    Brachmann A; Baxa U; Wickner RB
    EMBO J; 2005 Sep; 24(17):3082-92. PubMed ID: 16096644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prion filament networks in [URE3] cells of Saccharomyces cerevisiae.
    Speransky VV; Taylor KL; Edskes HK; Wickner RB; Steven AC
    J Cell Biol; 2001 Jun; 153(6):1327-36. PubMed ID: 11402074
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Architecture of Ure2p prion filaments: the N-terminal domains form a central core fiber.
    Baxa U; Taylor KL; Wall JS; Simon MN; Cheng N; Wickner RB; Steven AC
    J Biol Chem; 2003 Oct; 278(44):43717-27. PubMed ID: 12917441
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conservation of a portion of the S. cerevisiae Ure2p prion domain that interacts with the full-length protein.
    Edskes HK; Wickner RB
    Proc Natl Acad Sci U S A; 2002 Dec; 99 Suppl 4(Suppl 4):16384-91. PubMed ID: 12177423
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary sequence independence for prion formation.
    Ross ED; Edskes HK; Terry MJ; Wickner RB
    Proc Natl Acad Sci U S A; 2005 Sep; 102(36):12825-30. PubMed ID: 16123127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prion domain initiation of amyloid formation in vitro from native Ure2p.
    Taylor KL; Cheng N; Williams RW; Steven AC; Wickner RB
    Science; 1999 Feb; 283(5406):1339-43. PubMed ID: 10037606
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the prion domain of soluble Ure2p unstructured?
    Pierce MM; Baxa U; Steven AC; Bax A; Wickner RB
    Biochemistry; 2005 Jan; 44(1):321-8. PubMed ID: 15628874
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amyloid of the Candida albicans Ure2p prion domain is infectious and has an in-register parallel β-sheet structure.
    Engel A; Shewmaker F; Edskes HK; Dyda F; Wickner RB
    Biochemistry; 2011 Jul; 50(27):5971-8. PubMed ID: 21634787
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ure2p function is enhanced by its prion domain in Saccharomyces cerevisiae.
    Shewmaker F; Mull L; Nakayashiki T; Masison DC; Wickner RB
    Genetics; 2007 Jul; 176(3):1557-65. PubMed ID: 17507672
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure of the globular region of the prion protein Ure2 from the yeast Saccharomyces cerevisiae.
    Bousset L; Belrhali H; Janin J; Melki R; Morera S
    Structure; 2001 Jan; 9(1):39-46. PubMed ID: 11342133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The [URE3] prion is an aggregated form of Ure2p that can be cured by overexpression of Ure2p fragments.
    Edskes HK; Gray VT; Wickner RB
    Proc Natl Acad Sci U S A; 1999 Feb; 96(4):1498-503. PubMed ID: 9990052
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Characterization of oligomeric species in the fibrillization pathway of the yeast prion Ure2p.
    Catharino S; Buchner J; Walter S
    Biol Chem; 2005 Jul; 386(7):633-41. PubMed ID: 16207084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural characterization of the fibrillar form of the yeast Saccharomyces cerevisiae prion Ure2p.
    Bousset L; Redeker V; Decottignies P; Dubois S; Le Maréchal P; Melki R
    Biochemistry; 2004 May; 43(17):5022-32. PubMed ID: 15109261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The mechanisms of [URE3] prion elimination demonstrate that large aggregates of Ure2p are dead-end products.
    Ripaud L; Maillet L; Cullin C
    EMBO J; 2003 Oct; 22(19):5251-9. PubMed ID: 14517262
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A model for Ure2p prion filaments and other amyloids: the parallel superpleated beta-structure.
    Kajava AV; Baxa U; Wickner RB; Steven AC
    Proc Natl Acad Sci U S A; 2004 May; 101(21):7885-90. PubMed ID: 15143215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Scrambled prion domains form prions and amyloid.
    Ross ED; Baxa U; Wickner RB
    Mol Cell Biol; 2004 Aug; 24(16):7206-13. PubMed ID: 15282319
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structure and assembly properties of the N-terminal domain of the prion Ure2p in isolation and in its natural context.
    Bousset L; Bonnefoy J; Sourigues Y; Wien F; Melki R
    PLoS One; 2010 Mar; 5(3):e9760. PubMed ID: 20339590
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.